AbbVie Inc.

02/07/2025 | Press release | Distributed by Public on 02/07/2025 12:28

U.S. FDA Approves EMBLAVEO™ (aztreonam and avibactam) for the Treatment of Adults With Complicated Intra-Abdominal Infections With Limited or No Treatment Options